
An overview of the available zzso evidence on the connection between oral zzso and cancer or vascular disease is zzso including the observation that zzso studies have produced important indications for changing both the composition and prescription patterns of oral zzso to avoid a large proportion of vascular side zzso Further, the evidence is remarkably clear and consistent in relation to the elevated risks of cervical zzso and, although based on a limited number of small studies, of primary liver zzso protection against zzso and zzso zzso up to middle zzso and the absence of association with zzso zzso There are still uncertainties regarding breast cancer, mainly related to the role of time factors, and the potential zzso risk related to long term use at younger age: published studies, in fact, show elevated risks for long term use in women below age 35 or perhaps up to age 45, but no evidence of association in middle zzso Since breast cancer and zzso cancer account for most of the mortality burden in women up to age 50 or 55 in developed countries, a clarification of the risk relationship for these 2 zzso will determine most of the quantitative evaluation on positive or adverse effects of oral zzso The impact of other zzso and of cardiovascular disease, on the basis of current oral contraceptive zzso is comparatively zzso if not zzso 

